SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001509190-17-000031
Filing Date
2017-05-09
Accepted
2017-05-09 16:33:24
Documents
77
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q petx-20170331x10q.htm 10-Q 1300148
2 EX-31.1 petx-20170331xex31_1.htm EX-31.1 20015
3 EX-31.2 petx-20170331xex31_2.htm EX-31.2 20347
4 EX-32.1 petx-20170331xex32_1.htm EX-32.1 6788
5 EX-32.2 petx-20170331xex32_2.htm EX-32.2 7597
6 GRAPHIC petx-20170331x10qg001.jpg GRAPHIC 42898
  Complete submission text file 0001509190-17-000031.txt   6036619

Data Files

Seq Description Document Type Size
7 EX-101.INS petx-20170331.xml EX-101.INS 1399472
8 EX-101.SCH petx-20170331.xsd EX-101.SCH 47819
9 EX-101.CAL petx-20170331_cal.xml EX-101.CAL 51040
10 EX-101.DEF petx-20170331_def.xml EX-101.DEF 153313
11 EX-101.LAB petx-20170331_lab.xml EX-101.LAB 343086
12 EX-101.PRE petx-20170331_pre.xml EX-101.PRE 301558
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 17826947
SIC: 2834 Pharmaceutical Preparations